Skip to main content
. 2014 May 2;8:421–429. doi: 10.2147/DDDT.S63320

Table 2.

TGF-β, FGF-β, and PDGF immunostaining intensities in the study groups

Study group TGF-β immunostaining intensity (mean ± SD) FGF-β immunostaining intensity (mean ± SD) PDGF immunostaining intensity (mean ± SD)
Control (n=7) 1.87±0.35 1.87±0.35 1.50±0.53
Sham (n=7) 2.85±0.37a 3.00±0.0a 2.85±0.37a
MMC (n=7) 1.42±0.53b 1.57±0.53b 1.71±0.53b
Infliximab (n=7) 1.37±0.51b 1.37±0.51b 1.50±0.51b

Notes:

a

Control group compared with sham group (P<0.01);

b

treatment groups compared with sham group (P<0.01).

Abbreviations: FGF-β, fibroblast growth factor beta; PDGF, platelet-derived growth factor; SD, standard deviation; TGF-β, transforming growth factor beta; MMC, mitomycin-C.